menu search

Ibio further expands tech stack with shieldtx™; enhances immuno-oncology development pipeline with conditionally activated muc16xcd3 bispecific

– ShieldTx potentially increases safety and developability of therapeutic antibodies for difficult ta...

November 1, 2023, 12:24 pm

Zoetis: significant capex investments for long-term growth, but a hold now

Zoetis is an animal health company specializing in the development and manufacturing of veterinary pharmaceuticals and vaccines for both livestock and...

October 26, 2023, 1:18 am

Merus announces business update conference call

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Oct. 15, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinica...

October 15, 2023, 7:58 pm

Opko health (opk) gets barda contract to combat antibody threats

OPKO Health's (OPK) latest awarded funding is likely to enable the development of novel multispecific antibodi...

October 6, 2023, 1:32 pm

Modex therapeutics secures barda contract to develop novel multispecific antibodies against viral infectious disease threats

Provides Initial $59 Million and up to $168 Million Contingent on Milestones NATICK, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) — ModeX Therapeutics Inc...

September 28, 2023, 8:08 pm

Kineta to present new preclinical data on lead anti-cd27 agonist antibody at aacr special conference on tumor immunology and immunotherapy

SEATTLE, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu...

September 25, 2023, 9:30 am

Actinium pharmaceuticals trickling down through 2023: are they flying under the radar?

Actinium is making radiolabeled antibodies for use in hematologic cancers. Previously reported phase 3 ...

September 15, 2023, 7:02 pm

Moderna vaccine effective against latest covid strain

Moderna Therapeutics Inc (NASDAQ:MRNA) has told investors that its revised Covid vaccine appears effective against the BA.2.86 subvariant, a highly mu...

September 6, 2023, 9:26 am

Moderna says updated covid vaccine effective against ba.2.86 pirola variant

Moderna Inc. MRNA on Wednesday released clinical trial data indicating that its updated COVID-19 vaccination is effective against the BA.2.86 Pirola v...

September 6, 2023, 8:12 am

Abcam agrees to be acquired by danaher in $5.7b deal

Abcam Plc stock ABCM, +3.87% was up 0.4% in premarket trades Monday after it said it agreed to be acquired by Danaher Corp. DHR, +0.78% for $24 a shar...

August 28, 2023, 7:54 am

Moderna says updated covid vaccine effective against widely circulating eris variant

Moderna Inc. said Thursday that preliminary clinical trial data show that its updated COVID-19 vaccine is effective against newer variants that are st...

August 17, 2023, 4:45 pm

Comera life sciences announces publication of study reinforcing caffeine’s viscosity reducing capabilities

Data published in the Journal of Pharmaceutical Sciences support further development of caffeine as a viscosity reducing agent for subcutaneous formul...

August 16, 2023, 12:00 pm

Igm biosciences announces second quarter 2023 financial results

– Continued progress in clinical development across portfolio –– Public equity offering and concurrent private placement with gross proceeds of ...

August 3, 2023, 8:10 pm

Xencor to host second quarter 2023 financial results webcast and conference call on august 3, 2023

PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered ...

July 27, 2023, 8:01 am

Genprex granted chinese patent for lead drug candidate reqorsa with pd-1 antibodies to treat cancers

Genprex Inc. revealed that the China National Intellectual Property Administration has granted it a broad patent, which covers the use of its lead dru...

July 5, 2023, 9:47 am

Moonlake immunotherapeutics makes a moonshot on trials

Clinical stage biotech MoonLake Immunotherapeutics AG NASDAQ: MLTX shares spiked 70% on positive phase two clinical trial results. The company special...

June 28, 2023, 9:06 am

Immunogen stock continues to defy gravity on phase 2 trials

ImmunoGen Inc. NASDAQ: IMGN is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles...

June 26, 2023, 8:13 am

Cell dissociation market set to top a valuation of us$ 1257.59 million by 2033 & exhibit a cagr of 13.55% over the forecast period | future market insights, inc.

Cell dissociation, also known as trypsinization, is the process of separating adherent cells from the cell culture vessel by breaking down proteins wi...

June 8, 2023, 12:30 am

Monoclonal antibodies market sales are anticipated to reach us$ 588.0 billion by 2032, increasing at 11.8% cagr: market.us report

Across the world, the market is experiencing a surge in growth primarily attributed to the increasing prevalence of chronic diseases among patients. F...

May 26, 2023, 5:50 am

Sab biotherapeutics presents virtual 2023 r&d day portfolio update: breakthrough immunotherapy innovations

SIOUX FALLS, S.D., May 19, 2023 (GLOBE NEWSWIRE) — SAB Biotherapeutics (NASDAQ: SABS), a clinical-stage biopharmaceutical company with a novel immun...

May 19, 2023, 12:30 pm


Search within

Pages Search Results: